Cargando…

Altered serum level of metabolic and endothelial factors in patients with systemic sclerosis

Systemic sclerosis (SSc) is a chronic connective tissue disease characterized by progressive fibrosis, vascular impairment and immune abnormalities. In recent years, adipokines (mediators synthetized by adipose tissue) have been indicated as a possible missing link in the pathogenesis of SSc. The ai...

Descripción completa

Detalles Bibliográficos
Autores principales: Stochmal, Anna, Czuwara, Joanna, Zaremba, Michał, Rudnicka, Lidia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7306018/
https://www.ncbi.nlm.nih.gov/pubmed/31667578
http://dx.doi.org/10.1007/s00403-019-01993-y
_version_ 1783548575132680192
author Stochmal, Anna
Czuwara, Joanna
Zaremba, Michał
Rudnicka, Lidia
author_facet Stochmal, Anna
Czuwara, Joanna
Zaremba, Michał
Rudnicka, Lidia
author_sort Stochmal, Anna
collection PubMed
description Systemic sclerosis (SSc) is a chronic connective tissue disease characterized by progressive fibrosis, vascular impairment and immune abnormalities. In recent years, adipokines (mediators synthetized by adipose tissue) have been indicated as a possible missing link in the pathogenesis of SSc. The aim of this study was to investigate the serum concentration of metabolic adipose tissue factors: adiponectin, resistin, leptin and endothelial proteins: endothelin-1, fractalkine and galectin-3 in patients with systemic sclerosis. The study included 100 patients with confirmed SSc diagnosis and 20 healthy individuals. The concentration of respective proteins was determined by enzyme-linked immunosorbent assay. The following markers showed statistically significant increased mean concentrations in patients with SSc in comparison to healthy control: resistin (13.41 vs 8.54 ng/mL; P = 0.0012), endothelin-1 (1.99 vs 1.31 pg/mL; P = 0.0072) and fractalkine (2.93 vs 1.68 ng/mL; P = 0.0007). Elevated serum levels of galectin-3 (4.54 vs 3.26 ng/mL; P = 0.0672) and leptin (19,542 vs 14,210 pg/mL; P = 0.1817) were observed. Decreased concentration of adiponectin was found in patients with SSc (5150 vs 8847 pg/mL; P = 0.0001). Fractalkine and galectin-3 levels were significantly higher in diffuse cutaneous SSc than limited cutaneous SSc subset (3.93 ng/mL vs 2.58 ng/mL, P = 0.0018; 6.86 ng/mL vs 3.78 ng/mL, P = 0.0008, respectively) and correlated positively with modified Rodnan Skin Score in total SSc patients (r = 0.376, P = 0.0009; r = 0.236, P = 0.018, respectively). In conclusion, an increased serum level of resistin associated with increased endothelin-1 and fractalkine level and decreased adiponectin level may indicate a significant role of the adipose tissue in the development and progression of vascular abnormalities in patients with systemic sclerosis. Fractalkine and galectin-3 may participate in promoting and exacerbating the fibrotic process in SSc.
format Online
Article
Text
id pubmed-7306018
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-73060182020-06-22 Altered serum level of metabolic and endothelial factors in patients with systemic sclerosis Stochmal, Anna Czuwara, Joanna Zaremba, Michał Rudnicka, Lidia Arch Dermatol Res Concise Communications Systemic sclerosis (SSc) is a chronic connective tissue disease characterized by progressive fibrosis, vascular impairment and immune abnormalities. In recent years, adipokines (mediators synthetized by adipose tissue) have been indicated as a possible missing link in the pathogenesis of SSc. The aim of this study was to investigate the serum concentration of metabolic adipose tissue factors: adiponectin, resistin, leptin and endothelial proteins: endothelin-1, fractalkine and galectin-3 in patients with systemic sclerosis. The study included 100 patients with confirmed SSc diagnosis and 20 healthy individuals. The concentration of respective proteins was determined by enzyme-linked immunosorbent assay. The following markers showed statistically significant increased mean concentrations in patients with SSc in comparison to healthy control: resistin (13.41 vs 8.54 ng/mL; P = 0.0012), endothelin-1 (1.99 vs 1.31 pg/mL; P = 0.0072) and fractalkine (2.93 vs 1.68 ng/mL; P = 0.0007). Elevated serum levels of galectin-3 (4.54 vs 3.26 ng/mL; P = 0.0672) and leptin (19,542 vs 14,210 pg/mL; P = 0.1817) were observed. Decreased concentration of adiponectin was found in patients with SSc (5150 vs 8847 pg/mL; P = 0.0001). Fractalkine and galectin-3 levels were significantly higher in diffuse cutaneous SSc than limited cutaneous SSc subset (3.93 ng/mL vs 2.58 ng/mL, P = 0.0018; 6.86 ng/mL vs 3.78 ng/mL, P = 0.0008, respectively) and correlated positively with modified Rodnan Skin Score in total SSc patients (r = 0.376, P = 0.0009; r = 0.236, P = 0.018, respectively). In conclusion, an increased serum level of resistin associated with increased endothelin-1 and fractalkine level and decreased adiponectin level may indicate a significant role of the adipose tissue in the development and progression of vascular abnormalities in patients with systemic sclerosis. Fractalkine and galectin-3 may participate in promoting and exacerbating the fibrotic process in SSc. Springer Berlin Heidelberg 2019-10-30 2020 /pmc/articles/PMC7306018/ /pubmed/31667578 http://dx.doi.org/10.1007/s00403-019-01993-y Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Concise Communications
Stochmal, Anna
Czuwara, Joanna
Zaremba, Michał
Rudnicka, Lidia
Altered serum level of metabolic and endothelial factors in patients with systemic sclerosis
title Altered serum level of metabolic and endothelial factors in patients with systemic sclerosis
title_full Altered serum level of metabolic and endothelial factors in patients with systemic sclerosis
title_fullStr Altered serum level of metabolic and endothelial factors in patients with systemic sclerosis
title_full_unstemmed Altered serum level of metabolic and endothelial factors in patients with systemic sclerosis
title_short Altered serum level of metabolic and endothelial factors in patients with systemic sclerosis
title_sort altered serum level of metabolic and endothelial factors in patients with systemic sclerosis
topic Concise Communications
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7306018/
https://www.ncbi.nlm.nih.gov/pubmed/31667578
http://dx.doi.org/10.1007/s00403-019-01993-y
work_keys_str_mv AT stochmalanna alteredserumlevelofmetabolicandendothelialfactorsinpatientswithsystemicsclerosis
AT czuwarajoanna alteredserumlevelofmetabolicandendothelialfactorsinpatientswithsystemicsclerosis
AT zarembamichał alteredserumlevelofmetabolicandendothelialfactorsinpatientswithsystemicsclerosis
AT rudnickalidia alteredserumlevelofmetabolicandendothelialfactorsinpatientswithsystemicsclerosis